Spineguard SA
PAR:ALSGD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/GP
Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.
Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.
Valuation Scenarios
If EV/GP returns to its 3-Year Average (3.4), the stock would be worth €0.11 (11% upside from current price).
| Scenario | EV/GP Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 3 | €0.1 |
0%
|
| 3-Year Average | 3.4 | €0.11 |
+11%
|
| 5-Year Average | 3.9 | €0.12 |
+27%
|
| Industry Average | 3 | €0.1 |
-1%
|
| Country Average | 3 | €0.1 |
-1%
|
Forward EV/GP
Today’s price vs future gross profit
Peer Comparison
| Market Cap | EV/GP | P/E | ||||
|---|---|---|---|---|---|---|
| FR |
|
Spineguard SA
PAR:ALSGD
|
9.1m EUR | 3 | -4.4 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
162.5B USD | 23.6 | 56.9 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
157.7B USD | 6.2 | 25.1 | |
| US |
|
Stryker Corp
NYSE:SYK
|
120.5B USD | 8.1 | 37.1 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
103.9B USD | 5.3 | 22.5 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
85.4B USD | 6.6 | 24 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48.5B USD | 9.1 | 44.2 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
39.3B EUR | 5.2 | 18.6 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
44.7B USD | 16.9 | 42.2 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
42.4B USD | 5.8 | 24.2 | |
| US |
|
Resmed Inc
NYSE:RMD
|
31.1B USD | 9.2 | 21 |
Market Distribution
| Min | 0.1 |
| 30th Percentile | 1.7 |
| Median | 3 |
| 70th Percentile | 4.7 |
| Max | 5 681.3 |
Other Multiples
Spineguard SA
Glance View
Spineguard SA engages in the design and manufacture of medical devices for the spine. The company is headquartered in Vincennes, Ile-De-France. The company went IPO on 2013-04-29. The firm involves with the DSG (Dynamic Surgical Guidance) technology that concentrates on the placement of bone implants for the benefit of patients, surgeons, hospital staff, and healthcare systems. The DSG digital technology platform is a real-time surgical guidance work based on the measurement of local electrical conductivity of tissues without X-rays that includes PediGuard devices, the manual instruments capable of alerting surgeons in real time to potential pedicle or vertebral breaches. The technology is also implemented for the surgical robots to improve the safety, accuracy and autonomy.
